Related Experiment Videos
New issues in cancer risk assessment
1National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079.
Drug Metabolism Reviews
|April 25, 2000
Summary
This study proposes a unified risk assessment procedure for carcinogens using benchmark doses and uncertainty factors. It suggests relative risk assessment for improved cross-species extrapolation, potentially reducing human cancer risk estimates.
Area of Science:
- Toxicology
- Risk Assessment
- Carcinogenesis
Background:
- Establishing acceptable daily intake (ADI) for carcinogens often relies on dose-response extrapolation.
- Uncertainty factors are crucial for accounting for interspecies differences and human variability.
Purpose of the Study:
- To propose a unified risk assessment procedure for carcinogens.
- To explore the use of mechanistic data for refining uncertainty factors.
- To examine cross-species extrapolation using relative risk versus excess risk.
Main Methods:
- Utilizing benchmark dose (BMD) associated with low tumor incidence in animals.
- Applying uncertainty factors for extrapolation and risk reduction.
- Comparing relative risk approach with excess risk for cross-species extrapolation.
Main Results:
- A nonlinear dose-response approach with justified mechanistic information allows for smaller uncertainty factors.
- Linear extrapolation from BMD can yield similar results when nonlinear responses are not justified.
- The relative risk approach may reduce human cancer risk estimates compared to excess risk.
Conclusions:
- A unified risk assessment procedure based on uncertainty factors is feasible.
- Mechanistic data can optimize uncertainty factor selection.
- The relative risk approach offers a potentially more accurate method for cross-species extrapolation of carcinogen risk.